Pharmaceuticals India News
  • Home
  • Brands
    • Alkem
    • Apollo Hospital
    • Aurobindo Pharma
    • Biocon
    • Cipla
    • Divi’s Laboratories
    • Dr Reddy’s
    • Fortis
    • Glenmark
    • Lupin
    • Mankind Pharma
    • Natco
    • Pfizer
    • Piramal Pharma
    • Sun Pharma
    • Torrent Pharma
    • Zydus
Select Page

Mankind Pharma appoints Dapinder Singh Narula as new Head of Talent Management, reports People Matters.

by Team Small News | May 18, 2025 | Mankind, Pfizer, Pharma

Dapinder Singh Narula has been appointed to lead the Talent Management function at Mankind Pharma, a leading Indian pharmaceutical company. In this exclusive interview with People Matters, Narula shared his vision and strategies for talent management in the...

Earnings Alert: Upcoming Q4 Results Include ITC, Hindalco, Pfizer, Power Grid, IndusInd Bank, RVNL, JSW Steel, and Others on Goodreturns

by Team Small News | May 17, 2025 | Pfizer, Pharma

Next week is expected to be a busy one for corporate earnings, with several major companies set to announce their Q4 results. The list of companies includes ITC, Hindalco, Pfizer, Power Grid, IndusInd Bank, RVNL, and JSW Steel, among others. ITC, one of India’s...

As India crosses the ‘Tropic of Cancer’ in terms of rising caseload, Pfizer announces plans to introduce novel oncology treatments.

by Team Small News | May 16, 2025 | Pfizer, Pharma

India is facing a significant rise in cancer cases, with estimates suggesting that 1 in 9 Indians is at risk of developing cancer in their lifetime. To address this growing issue, American pharmaceutical company Pfizer is planning to launch several new oncology drugs...

The Antivenom Serum Market is Poised for a Significant Shift, with Key Players such as Pfizer, Sanofi, and VACSERA Taking the Lead.

by Team Small News | May 13, 2025 | Pfizer, Pharma

The global Antivenom Serum market is expected to grow from USD 0.65 billion in 2024 to USD 1.2 billion by 2031, at a compound annual growth rate (CAGR) of 9.2% during the forecast period. The market is driven by increasing research and development spending, growing...

Pfizer’s $15 Billion Acquisition Fund: What’s Next After Danuglipron Setback? – Insights from Baptista Research on Smartkarma

by Team Small News | May 10, 2025 | Pfizer, Pharma

Pfizer, one of the world’s largest pharmaceutical companies, has amassed a significant war chest of approximately $15 billion, sparking speculation about its potential acquisition targets. The company’s recent setback with Danuglipron, a potential...

GSK and Pfizer reach agreement to resolve patent dispute surrounding respiratory syncytial virus vaccine Arexvy

by Team Small News | May 6, 2025 | Pfizer, Pharma

GlaxoSmithKline (GSK) has reached a global patent settlement with Pfizer, ending a lengthy legal battle over a breakthrough lung disease vaccine. The settlement allows Pfizer to have a worldwide license to certain GSK patents related to its respiratory syncytial virus...
« Older Entries
Next Entries »

_________

Pharna Brands

  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma
  • Torrent Pharma
  • Zydus
  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Torrent Pharma
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Zydus
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma

    Designed by Elegant Themes | Powered by WordPress